Understanding the nicotine dose delivered by electronic nicotine delivery systems in a single puff: the importance of nicotine flux and puff duration
- PMID: 38897725
- PMCID: PMC11655706
- DOI: 10.1136/tc-2023-058485
Understanding the nicotine dose delivered by electronic nicotine delivery systems in a single puff: the importance of nicotine flux and puff duration
Abstract
Electronic nicotine delivery systems (ENDS) may lead to public health benefit if they help people who smoke quit smoking, and may lead to public health harm if they recruit a new generation of nicotine-dependent people. Regulators intent on maximising ENDS' public health benefit and minimising harm may be interested in regulating the nicotine dose delivered by ENDS in a single puff. The per-puff nicotine dose is the product of ENDS nicotine emission rate (or 'nicotine flux') and the duration of the puff taken by the person using the ENDS (or 'puff duration'). Nicotine flux can be measured or predicted mathematically for any ENDS device/liquid combination. Puff duration can be controlled electronically, as demonstrated by several ENDS marketed today. Combining nicotine flux and puff duration regulation is feasible today and provides authorities the means to limit nicotine dose per puff to a level that may help people who smoke quit smoking while reducing the possibility that nicotine-naive individuals will engage in repeated ENDS use. Tobacco regulatory science and product regulation will both be improved by a rigorous approach to understanding, characterising, and reporting the nicotine dose emitted by ENDS.
Keywords: Addiction; Electronic nicotine delivery devices; Nicotine; Smoking topography.
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: TE and AS are paid consultants in litigation against the tobacco industry and also the electronic cigarette industry and are named on one patent for a device that measures the puffing behaviour of electronic cigarette users and one patent for a smoking cessation intervention. TE is also named on a patent for a smartphone app that determines electronic cigarette device and liquid characteristics.
Similar articles
-
Constraining electronic nicotine delivery systems (ENDS) nicotine dose by controlling nicotine flux at a limited puff duration.Exp Clin Psychopharmacol. 2024 Oct;32(5):604-614. doi: 10.1037/pha0000719. Epub 2024 May 30. Exp Clin Psychopharmacol. 2024. PMID: 38815113
-
Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems.Drug Alcohol Depend. 2025 Jan 1;266:112508. doi: 10.1016/j.drugalcdep.2024.112508. Epub 2024 Nov 28. Drug Alcohol Depend. 2025. PMID: 39657440
-
Influence of nicotine form and nicotine flux on puffing behavior and mouth-level exposure to nicotine from electronic nicotine delivery systems.Drug Alcohol Depend. 2024 Jan 1;254:111052. doi: 10.1016/j.drugalcdep.2023.111052. Epub 2023 Dec 2. Drug Alcohol Depend. 2024. PMID: 38103538 Free PMC article.
-
Electronic cigarettes and nicotine harm-reduction.Curr Opin Psychol. 2019 Dec;30:29-34. doi: 10.1016/j.copsyc.2019.01.010. Epub 2019 Jan 28. Curr Opin Psychol. 2019. PMID: 30798019 Review.
-
Applying the Population Health Standard to the Regulation of Electronic Nicotine Delivery Systems.Nicotine Tob Res. 2021 May 4;23(5):780-789. doi: 10.1093/ntr/ntaa190. Nicotine Tob Res. 2021. PMID: 32960217 Free PMC article. Review.
Cited by
-
Nicotine Dosimetry in Evaluating Electronic Cigarettes Compared to Cigarette Smoking: Implications for Tobacco Regulatory Science.Chem Res Toxicol. 2025 Apr 21;38(4):686-694. doi: 10.1021/acs.chemrestox.4c00462. Epub 2025 Mar 17. Chem Res Toxicol. 2025. PMID: 40094483 Free PMC article.
References
-
- Talih S, Salman R, Karaoghlanian N, et al. Carbonyl emissions and heating temperatures across 75 nominally identical electronic nicotine delivery system products: do manufacturing variations drive pulmonary toxicant exposure? Chem Res Toxicol. 2023;36:342–346. doi: 10.1021/acs.chemrestox.2c00391. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources